Patents by Inventor Robert Dorr

Robert Dorr has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8987309
    Abstract: A 2-aryl-pyridylazole compound and derivatives useful in slowing the growth of cancer cells are disclosed. Also disclosed are methods of synthesizing the compound, methods of using pharmaceutical compositions containing the compound as an ingredient to slow the growth of cancer cells, and methods of treating cancer patients with pharmaceutical compositions containing the compound as an ingredient.
    Type: Grant
    Filed: April 19, 2010
    Date of Patent: March 24, 2015
    Assignees: The Translational Genomics Research Institute, The Arizona Board of Regents on behalf of the University of Arizona
    Inventors: Robert Dorr, Gary Flynn, Haiyong Han, Laurence Hurley, Arthur Y. Shaw
  • Publication number: 20120136029
    Abstract: A 2-aryl-pyridylazole compound and derivatives useful in slowing the growth of cancer cells are disclosed. Also disclosed are methods of synthesizing the compound, methods of using pharmaceutical compositions containing the compound as an ingredient to slow the growth of cancer cells, and methods of treating cancer patients with pharmaceutical compositions containing the compound as an ingredient.
    Type: Application
    Filed: April 19, 2010
    Publication date: May 31, 2012
    Applicants: UNIVERSITY OF ARIZONA, THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE
    Inventors: Robert Dorr, Gary Flynn, Haiyong Han, Laurence Hurley
  • Publication number: 20070213354
    Abstract: Compositions and methods for treating multiple sclerosis are disclosed herein. Embodiments of the present invention include methods of treating a multiple sclerosis patient via the administration of a therapeutically effective amount of a composition comprising a compound of the formula: wherein, R1 is heteroalkyl, heterocycloalkyl, or heteroaryl; R2, R4 and R6 are independently hydrogen, halogen, nitro, amino, hydroxy, C1-C6 alkyl, C1-C6 heteroalkyl, heterocycloalkyl or aryl; R3, R5, and R7 are independently hydrogen or C1-C6 alkyl, or R3 and R4 taken together with the carbon atoms to which they are attached form a phenyl ring, or R4 and R5 taken together with the carbon atoms to which they are attached form a phenyl ring, or R5 and R7 taken together with the carbon atoms to which they are attached form a phenyl ring; and n1 and n2 are independently 0, 1 or 2; or a pharmaceutically acceptable salt, a prodrug, or a mixture thereof.
    Type: Application
    Filed: March 1, 2007
    Publication date: September 13, 2007
    Applicant: AmpliMed Corporation
    Inventors: Robert Dorr, Evan Hersh, David Alberts
  • Publication number: 20050234812
    Abstract: A method is disclosed herein for displaying time lapse for an on-line auction for an item in a computer. According to the method, the processor time in the computer is obtained and compared to the official auction time for the items being auctioned in the on-line auction which is obtained from the on-line auction service. The users computer compares the obtained processor time to the obtained official auction time and correlates the end of time from the on-line auction service to a processor end of time which corresponds to the user's time. The computer then displays the time left correlated to the processor's time preferably in a visual countdown graphical icon.
    Type: Application
    Filed: June 14, 2005
    Publication date: October 20, 2005
    Inventor: Robert Dorr
  • Publication number: 20050176696
    Abstract: The present invention provides compositions useful in treating cancer. The compositions include a synergistic combination of an antineoplastic thiol-binding mitochondrial oxidant with an antineoplastic nucleic acid binding agent, an antineoplastic antimetabolite base analog, or docetaxel. Also provided are methods of assaying the synergistic effects of the combinations and methods of treating cancer using the synergistic combinations.
    Type: Application
    Filed: December 8, 2004
    Publication date: August 11, 2005
    Applicant: Regents of the University of Arizona
    Inventors: Robert Dorr, David Alberts, Evan Hersh
  • Publication number: 20050142078
    Abstract: A method of stimulating the production of melanin by the pigment-producing cells (keratinocytes and/or melanocytes) of the skin, in particular for the induction of skin tanning in humans, comprises administering alpha-MSH or an alpha-MSH analogue and exposing the skin to ultraviolet irradiation.
    Type: Application
    Filed: February 25, 2003
    Publication date: June 30, 2005
    Inventors: Robert Dorr, Norman Levine, Gregory Ertl, David Alberts
  • Patent number: 5049547
    Abstract: A pharmaceutically active composition comprising a pharmaceutically acceptable carrier and one or more alpha-MSH or analogues thereof for use in the stimulation of integumental melanocytes in vertebrates in order to bring about the production of melanin is disclosed.
    Type: Grant
    Filed: April 19, 1989
    Date of Patent: September 17, 1991
    Assignee: University Patents, Inc.
    Inventors: Victor J. Hruby, Mac E. Hadley, Robert Dorr, Norman Levine, Elizabeth Sugg, Wayne L. Cody
  • Patent number: 4918055
    Abstract: A method for stimulating integumental melanocytes by the topical application of alpha-MSH analogs, and compositions comprising said analogs for use in the method are described.
    Type: Grant
    Filed: February 11, 1988
    Date of Patent: April 17, 1990
    Inventors: Victor J. Hruby, Mac E. Hadley, Robert Dorr, Norman Levine
  • Patent number: 4866038
    Abstract: A method for stimulating integumental melanocytes by the topical application of alpha-MSH analogs, and compositions comprising said analogs for use in the method are described.
    Type: Grant
    Filed: July 22, 1988
    Date of Patent: September 12, 1989
    Assignee: University Patents, Inc.
    Inventors: Victor J. Hruby, Mac E. Hadley, Robert Dorr, Norman Levine, Elizabeth Sugg, Wayne L. Cody